Brooks O'Neil
Stock Analyst at Lake Street
(0.66)
# 4,118
Out of 5,152 analysts
34
Total ratings
29.41%
Success rate
-20.98%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXG MiMedx Group | Maintains: Buy | $12 → $10 | $4.75 | +110.53% | 2 | Jan 20, 2026 | |
| LFMD LifeMD | Maintains: Buy | $14 → $8 | $3.00 | +166.67% | 4 | Nov 18, 2025 | |
| TNDM Tandem Diabetes Care | Downgrades: Hold | $75 → $12 | $22.63 | -46.97% | 2 | Aug 11, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $14 → $8 | $4.78 | +67.36% | 7 | Aug 11, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $2.36 | +747.46% | 2 | Apr 21, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $106.15 | +3.63% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $11.11 | +170.03% | 1 | Feb 24, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $4.70 | +453.19% | 1 | Dec 19, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $36.17 | +52.06% | 3 | Oct 4, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $32 → $18 | $12.57 | +43.20% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $8.75 | +128.57% | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.90 | +72.41% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $24.38 | +6.64% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.20 | +5,372.64% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $23.16 | +450.52% | 1 | Sep 15, 2020 |
MiMedx Group
Jan 20, 2026
Maintains: Buy
Price Target: $12 → $10
Current: $4.75
Upside: +110.53%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $3.00
Upside: +166.67%
Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75 → $12
Current: $22.63
Upside: -46.97%
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $4.78
Upside: +67.36%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $2.36
Upside: +747.46%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $106.15
Upside: +3.63%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $11.11
Upside: +170.03%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $4.70
Upside: +453.19%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $36.17
Upside: +52.06%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $12.57
Upside: +43.20%
Aug 9, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $8.75
Upside: +128.57%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $2.90
Upside: +72.41%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $24.38
Upside: +6.64%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.20
Upside: +5,372.64%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $23.16
Upside: +450.52%